Loss of function of the BMPR2 protein or a decrease in its activity and the disturbance of its signaling pathways is a key and permissive event in the whole process of PAH pathogenesis—this also affects the change in phenotype in favor of anti-apoptotic and pro-proliferative ones [51,52]. Here, BMPR2 is linked to pulmonary arterial hypertension.